First Eagle Investment Management, LLC - TETRALOGIC PHARMACEUTICALS C ownership

TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 29 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
First Eagle Investment Management, LLC ownership history of TETRALOGIC PHARMACEUTICALS C
ValueSharesWeighting
Q4 2015$346,000
-43.5%
200,000
-38.6%
0.00%
-50.0%
Q3 2015$612,000
-19.7%
325,5590.0%0.00%0.0%
Q2 2015$762,000
+52.1%
325,559
+184.4%
0.00%
+100.0%
Q1 2015$501,000
-9.2%
114,4560.0%0.00%0.0%
Q4 2014$552,000
+16.0%
114,4560.0%0.00%0.0%
Q3 2014$476,000
-29.4%
114,4560.0%0.00%
-50.0%
Q2 2014$674,000
-30.9%
114,456
-25.1%
0.00%
-33.3%
Q1 2014$975,000152,8000.00%
Other shareholders
TETRALOGIC PHARMACEUTICALS C shareholders Q3 2015
NameSharesValueWeighting ↓
Clarus Ventures, LLC 4,644,705$8,035,0005.63%
First Washington CORP 317,450$549,0000.32%
NEXTHERA CAPITAL LP 64,000$111,0000.16%
MYCIO WEALTH PARTNERS, LLC 12,000$21,0000.00%
Weiss Multi-Strategy Advisers LLC 31,500$54,0000.00%
Burt Wealth Advisors 2,625$4,0000.00%
Tower Research Capital LLC (TRC) 6,008$10,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 18,553$32,0000.00%
WOODMONT INVESTMENT COUNSEL LLC 1,225$2,0000.00%
A.R.T. Advisors, LLC 14,358$24,0000.00%
View complete list of TETRALOGIC PHARMACEUTICALS C shareholders